Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 20/20 | 1.00 |
| ▸ | TUBB | P07437 | 20/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 20/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 20/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 20/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 20/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 20/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 20/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 20/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 20/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 20/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 20/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 20/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 20/20 | 1.00 |
| ▸ | TUBB1 | Q9H4B7 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Curacin A SCHEMBL14363315 | 1.00 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Curacin A SCHEMBL12379192 | 1.00 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL13135120 | 0.91 | TUBB4A (0.82) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL13857390 | 0.90 | TUBB4A (0.82) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29884561 | 0.88 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL12735921 | 0.62 | TUBB4A (0.48) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL2108688 | 0.51 | — | — | |
| SCHEMBL13764202 | 0.51 | TUBB4A (0.40) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1775924 | 0.50 | — | — | |
| SCHEMBL5058608 | 0.50 | CNR1 (0.41) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7999 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| EP-4479042-A1 | CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-12-25 | — | — | EP | claimed |
| US-20240400468-A1 | Bionutritional Compositions for Plants and Soils | ENVIROKURE, INCORPORATED (US) | 2024-12-05 | — | — | US | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| EP-4377280-A1 | BIONUTRITIONAL COMPOSITIONS FOR PLANTS AND SOILS | Envirokure Incorporated (US) | 2024-06-05 | — | — | EP | claimed |
| WO-2023158514-A1 | CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-24 | — | — | WO | claimed |
| US-20230263783-A1 | CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-08-24 | — | — | US | claimed |
| WO-2023009636-A1 | BIONUTRITIONAL COMPOSITIONS FOR PLANTS AND SOILS | ENVIROKURE, INCORPORATED (US) | 2023-02-02 | — | — | WO | claimed |
| US-11345956-B2 | Methods and compositions related to prostate cancer therapeutics | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-05-31 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20040092583-A1 | Treatment for inhibiting neoplastic lesions | SHANAHAN-PRENDERGAST ELIZABETH (IE) | 2004-05-13 | — | — | US | claimed |
| EP-1351678-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | Shanahan-Prendergast, Elizabeth (IE) | 2003-10-15 | — | — | EP | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20020037918-A1 | Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-03-28 | — | — | US | claimed |
| WO-2002006267-A2 | SYNTHESIS AND BIOLOGICAL EVALUATION OF ANALOGS OF THE ANTIMITOTIC MARINE NATURAL PRODUCT CURACIN A | UNIVERSITY OF PITTSBURGH (US) | 2002-01-24 | — | — | WO | claimed |
| WO-2000035865-A2 | TUBULIN-BINDING AGENTS | TULARIK INC. (US) | 2000-06-22 | — | — | WO | claimed |
| WO-1995009630-A1 | COMPOUNDS EXHIBITING ANTIPROLIFERATIVE ACTIVITY AGAINST CELLS | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1995-04-13 | — | — | WO | claimed |
| US-5324739-A | Curacin A and Curacin B isomers; antimitotics | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1994-06-28 | — | — | US | claimed |